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The plasmid-located gene cafl encoding the capsular antigen fraction I (Fl) of Yersiniu pestis was cloned and sequenced. The gene codes for a 
170 amino acid peptide with a deduced M, of 17.6 kDa. The signal peptide sequence was highly homologous to the E. co/i consensus ignal sequence. 
The Fl was assumed to have p-sheet structure for the most part. The region located between amino acids 100 and 150 was suggested to contain 
putative antigenic determinants and to stimulate T cells. 
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1, INTRODUCTION 
The ultimate goal of infectious disease research is 
their prevention. Vaccination is one of the most effec- 
tive ways in which that goal can be attained. It is 
necessary to know the gene structure and putative im- 
munogenic surface structures of antigens to create 
recombinant vaccines. 
More than 10 antigens have been isolated from Yer- 
sinia pestis. The capsular antigen fraction 1 (Fl) was 
shown to be a highly protective antigen among such 
thermolabile antigens as D, Fl, T, V and W [I). Some 
properties of the Fl structure have been studied recently 
[2], but the nucleotide and amino acid sequences have 
been unknown so far. Here, we report the cloning and 
sequencing of the Y. pestis cafl gene coding for the Fl , 
and the predicted secondary structure with potential an- 
tigenic determinants. 
2. MATERIALS AND METHODS 
2.1. Bacterial strains, plasmids and DNA manipulafions 
The E. co/i strains LE392 and HBIOI were used as transistent hosts 
for cosmid pHC79 [3], and pUC18 or f9 [4], respectively. Y. pestisF1 
positive vaccine strain EV was obtained from the Culture Collection, 
All-Union Antiplague Institute ‘Microb’, USSR. Cultures were grown 
overnight while shaking at 37°C in liquid LB or on solid medium sup- 
plemented with the relevant antibiotics for plasmid selection. 
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Isolation of plasmid DNA by alkali-lysis method, DNA cfoning 
and Maxam-Gilbert sequencing were performed essentially as 
described by 1Maniatis et al. 151. 
2.2. Construction of a gene library, screening, and subcloning 
The Y. pestis plasmid pFra DNA (about 110 kb in size) was partial- 
ly digested with EcoRI, ligated with EeoRIdigested cosmid pHC79 
and packaged in vitro. The library was amplified in E. coli LE392 and 
ApRTcR colonies selected were further screened for Fl production by 
enzyme immunoassay. The isolated cosmid ~153 containing a 40-kb 
fragment of pFra DNA was then digested with EcoRl and an 8.6kb 
fragment was cloned into pHC79. The resulting cosmid pFS2 was 
digested with SalI and Hind111 and a 4.5kb fragment was cloned into 
pUCI9. The plasmid pFS2-13 generated was used for gene sequenc- 
ing. The 1 .O-kb Alul fragment of pFS2-I 3 was cloned into the SmaI- 
digested pUCl8 (plasmid pF18L) and sequenced. 
2.3. Protein sequencing 
The Fl protein was isolated from culture medium and purified by 
polyacrylamide gel electrophoresis as described [2]. The N-terminus 
of the mature protein was identified by a PTH-amino acid analyzer 
(Model 120A, Applied Biosystems). 
2.4. Secondary structure and anrigenic determinant analysis 
Secondary structure of the Fl protein was predicted from the amino 
acid composition as described in (61, and by the amino acid sequence 
analyses [7,8]. Antigenic regions were predicted according t0 HOPp 
and Woods [9] or Karplus and Schulz [lo]. TheT cell antigenicity was 
predicted as reported in [I I]. 
3. RESULTS AND DISCUSSION 
3.1. Sequence of the caf 1 gene 
Subcloning experiments from cosmid ~153 allowed 
us to construct plasmid pFS2-13 carrying the cafZ gene 
(Fig. 1). Based on the results of transposon mutagenesis 
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Fig. 1. Sequencing strategy for the cqfl gene. Overlapping restriction 
fragments of pFSZ-13 and pFf8L were sequenced as indicated by 
arrows. Open boxes indicate cloned DNA fragments. The length of 
the gene and the direction of transcription are indicated by a hatched 
arrow. 
(data not shown), the Fl structural gene was localized 
near C(a1 and PstI sites. The sequencing strategy for 
cafZ is shown in Fig. 1. Nucleotide sequencing revealed 
that the cafl gene was located on the overlapping 1 .O-kb 
AM-Mu1 fragment (Fig. 2) included in pF18L (Fig. 1). 
The coding region for the Fl protein was 510 bp long. 
Although the 5 ’ -flanking region had putative promoter 
HpaI 
AAACAGGAACCACTAGCACATCTGTTAACTTTACAGATGCA~CCCATGTAC~ 
YTOTTFTS”NrTDLIODP** 
TCGTCTTGGi-TACccGCAG~CA~ATTCiTTGTTCGCT~AATTGGTTC~AAA~GGT~ 
133” ” L * I 0 s P D FFVPSIO s x G 0 
721 AACnccAGcAGGlAAATAcAC~GA~~T~TAACCGTAA~CGTATCTAA~CAATAATCC~ 
1SPL L * A 0 x Y T D *v I‘” Z” s N aEnd 
781 TATAGATAA.i.AGAlAAAGG~~TAiCCCCTC 
641 CrrTGAGCC~AACCCTCGC~TTTCTTAAT~AC~CATTG~TA~AAGAC~GACAAATTT~ 
901 TGTGAAGATCAATGTTAGG~ACTAATGCACAAAGCCAC~CCTCAATAG~TTTCACATA~ 
AlUI 
961 TACACTATTAGCTAAGAATAGAGAGCGCCAATATATA 
1521 TCACCTTAA 
Fig. 2. Nucleotide and deduced amino acid sequences of the Ye&r& 
pestis cafl gene. The presumed promoter (- 35, - lo), 
Shine-Dalgarno and terminator sequences are underlined. An arrow 
indicates the cleavage site. 
sequences imilar to the E. coii consensus sequences 
(-35, - 10) [ 121, Fl was not expressed in E. coli carry- 
ing pF18L. In the 3’-non-coding region, the revealed 
inverted repeat structure resembled the Rho- 
independent transcriptional termination signal of E. 
coli 1131 but the T-stretch following this terminator se- 
quence was not clearly identified. Thus, the cafr expres- 
sion can be regulated in a complex manner and the gene 
may have a distinct transcriptional termination of its 
own. 
A putative ribosome binding site GAGGT was 
localized at 5 bp upstream from the ATG codon. An 
open reading frame from nucleotides 264 to 773 codes 
for a 170-aa polypeptide with a deduced I’@ of 17.6 
kDa. A potential signal peptide sequence has been iden- 
tified with a typical cleavage site (/): 
Ala-Thr-Ala-Asn-Ala/Ala-Asp which resembled the 
procaryotic consensus signal sequence [ 14f: Ala-%:- 
Ala-L!: -Ala/Ala- . k%,P This yields a leader peptide of 
21 residues and a secreted Fl of 149 residues with a 
deduced Mr of 15.5 kDa and p1 4.3. The amino acid 
composition of the Fl as deduced from the nucleotide 
sequence shows agreement with the data reported 
(2,151, except hat the Fl sequence does not contain Cys 
and Trp. 
3.2. Secondary structure and antigenically active 
epitopes 
Fig. 3A demonstrates that the Fl protein has mainly 
P-sheet structure (at least 50~0) and may have 3 or 4 
short strips of a-helix. Hydrophilicity and antigenicity 
profiles are presented in Fig. 3B. The region between 
residues 1051120 was supposed to be located on the pro- 
tein surface, since it contains P-turns, and furthermore, 
may constitute antigenic determinants. The second 
putative B cell epitope was assumed to be located in the 
C-terminus (149/161) whereas there was no clearly 
1 A 
amino acid number 
Fig. 3. Analysis of the Fl sequence. (A) The protein secondary 
structure determined according to [7] (top) and [8] (bottom). The 
boxes indicate o-helix and the zig-zags indicate p-sheet structure. (B) 
Hydrophilicity (top) and antigenicity (bottom) profiles of the Fl 
protein determined according to [9] and [lo], respectively. 
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identified hydrophilic maximum in this region. DeLisi 
and Berzofsky [17] concluded that amphipathic struc- 
tures (peptides with non-random secondary structures 
with opposing hydrophobic and hydrophilic surfaces) 
correlated with T cell antigenicity. Predicted T cell 
epitopes were localized between residues 106/ 115, 
127/135, and 1371148. 
Thus, the C-terminal region of the Fl antigen 
(100/150 residues) was supposed to be of great impor- 
tance for the immunogenicity of the Fl. 
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